REPEAT - Media Advisory -- Health care crisis unfolding in northwestern Ontario: community leaders demand Ford government act urgently
September 13, 2024 08:00 ET
|
Ontario Health Coalition
TORONTO and RAINY RIVER and THUNDER BAY and EMO, Ontario, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Hospital, EMS, and primary care services are at risk in northwestern Ontario due to a funding dispute...
North America Clot Management Devices Market Outlook to 2033 Featuring Boston Scientific, Inari Medical, Medtronic, Penumbra, and Teleflex
September 13, 2024 07:08 ET
|
Research and Markets
Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "North America Clot Management Devices Market Outlook to 2033 - Inferior Vena Cava Filters (IVCF), Embolectomy Balloon Catheters and Others" report has...
Media Advisory -- Health care crisis unfolding in northwestern Ontario: community leaders demand Ford government act urgently
September 12, 2024 14:02 ET
|
Ontario Health Coalition
TORONTO and RAINY RIVER and THUNDER BAY and EMO, Ontario, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Hospital, EMS, and primary care services are at risk in northwestern Ontario due to a funding dispute...
Uniti Group Inc. to Present at the RBC Capital Markets 2024 Global Communications Infrastructure Conference
September 11, 2024 16:15 ET
|
Uniti Group Inc.
LITTLE ROCK, Ark., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its President and Chief Executive Officer, Kenny Gunderman, is scheduled to...
Excision BioTherapeutics Announces Oral Presentation at the 2024 International HBV Meeting
September 09, 2024 08:00 ET
|
Excision BioTherapeutics
SAN FRANCISCO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious...
Regeneron to Highlight Progress Across Its Differentiated Oncology Portfolio and Pipeline at WCLC and ESMO
September 09, 2024 07:00 ET
|
Regeneron Pharmaceuticals, Inc.
At WCLC, five-year survival data to be presented on Libtayo (PD-1 inhibitor) first-line monotherapy in advanced non-small cell lung cancer At ESMO, longer-term results with investigational fianlimab...
Methode Electronics, Inc. Reports Fiscal 2025 First Quarter Financial Results
September 05, 2024 07:00 ET
|
Methode Electronics, Inc.
Adjusted Pre-Tax Loss Better than ExpectedNet Cash Provided by Operating Activities Up $16.5 MillionGuidance for Fiscal Years 2025 and 2026 AffirmedLaura Kowalchik Appointed Chief Financial...
DZS Files Q2 2024 Financial Results
September 03, 2024 08:16 ET
|
DZS
DALLAS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- DZS (OTC: DZSI), a developer of Networking and Connectivity solutions enabling broadband everywhere, today announced it has filed Q2 2024 financial...
Notable Labs to Present Data on September 4th at SOHO 2024
August 29, 2024 07:30 ET
|
Notable Labs
Society of Hematologic Oncology (SOHO) session to highlight volasertib program Phase 2 volasertib AML program expected to begin in the coming months FOSTER CITY, Calif., Aug....
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024 08:00 ET
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will be participating in the H.C. Wainwright 26th...